Maternal Serum Screening Markers and Adverse Outcome: A New Perspective.

Krantz, David; Hallahan, Terrence; Janik, David; Carmichael, Jonathan

Krantz, David; Hallahan, Terrence; Janik, David; Carmichael, Jonathan.

Afiliação

Krantz D; PerkinElmer Labs/NTD, 80 Ruland Road, Suite 1, Melville, NY 11747, USA. david.krantz@perkinelmer.com.
Hallahan T; PerkinElmer Labs/NTD, 80 Ruland Road, Suite 1, Melville, NY 11747, USA. terry.hallahan@perkinelmer.com.
Janik D; PerkinElmer Labs/NTD, 80 Ruland Road, Suite 1, Melville, NY 11747, USA. david.janik@perkinelmer.com.
Carmichael J; PerkinElmer Labs/NTD, 80 Ruland Road, Suite 1, Melville, NY 11747, USA. jon.carmichael@perkinelmer.com.

J Clin Med ; 3(3): 693-712, 2014 Jul 03.

Article em En | MEDLINE | ID: mdl-26237472

Palavras-chave

IUGR; aneuploidy screening; fetal loss; open neural tube defects; placenta accreta; preeclampsia; preterm birth

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google